{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:58:34Z","timestamp":1781089114480,"version":"3.54.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Leflunomide is an effective disease-modifying antirheumatic drug for rheumatoid arthritis, but it can rarely cause severe hematologic toxicity such as pancytopenia or agranulocytosis. These complications may predispose patients to life-threatening infections, even in the absence of concomitant myelosuppressive therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary:<\/jats:title>\n                    <jats:p>A 61-year-old man with newly diagnosed rheumatoid arthritis developed profound pancytopenia and agranulocytosis after 2 months of leflunomide monotherapy. He presented with septic shock requiring vasopressors and mechanical ventilation. Broad-spectrum antimicrobials, granulocyte colony-stimulating factor, and supportive critical-care management were initiated, and leflunomide was discontinued. Despite aggressive interventions, cytopenias persisted and multiorgan failure progressed, leading to death on hospital day 5. Postmortem bone-marrow biopsy demonstrated severe hypocellularity consistent with drug-induced marrow suppression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Severe pancytopenia or agranulocytosis caused by leflunomide monotherapy is extremely uncommon, with only isolated cases reported. Key management strategies include immediate drug cessation, broad antimicrobial coverage, hematologic support, and consideration of cholestyramine washout to accelerate drug clearance. In this case, adjunctive oXiris hemoadsorption provided transient hemodynamic improvement but did not reverse marrow failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Clinicians should maintain a high index of suspicion for drug-induced bone-marrow suppression in patients receiving leflunomide who develop unexplained cytopenias. Early drug discontinuation, aggressive supportive therapy, and timely initiation of cholestyramine washout may improve outcomes in this rare but life-threatening complication.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000047138","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:02:04Z","timestamp":1769191324000},"page":"e47138","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Leflunomide-induced pancytopenia and agranulocytosis resulting in septic shock: A case report"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8179-0486","authenticated-orcid":false,"given":"Wei-Hung","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, MacKay Memorial Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chao","family":"Chien","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, MacKay Memorial Hospital, Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8251-3808","authenticated-orcid":false,"given":"Ting-Yu","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, MacKay Memorial Hospital, Taipei, Taiwan"},{"name":"Department of Medicine, MacKay Medical College, New Taipei City, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20260610","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/0885066615610108","article-title":"Use of a cholestyramine washout in a patient with septic shock on leflunomide therapy: a case report and review of the literature.","volume":"31","author":"Laub","year":"2016","journal-title":"J Intensive Care Med"},{"key":"R3-20260610","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1345\/aph.1E012","article-title":"Leflunomide-associated pancytopenia with or without methotrexate.","volume":"38","author":"Chan","year":"2004","journal-title":"Ann Pharmacother"},{"key":"R4-20260610","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1177\/0885066619837139","article-title":"The performance of diagnostic criteria for hemophagocytic lymphohistiocytosis in critically ill patients.","volume":"35","author":"Meena","year":"2020","journal-title":"J Intensive Care Med"},{"key":"R5-20260610","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1563-2571.2000.00034.x","article-title":"Severe pancytopenia after leflunomide in rheumatoid arthritis.","volume":"27","author":"Auer","year":"2000","journal-title":"Acta Med Austriaca"},{"key":"R6-20260610","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1097\/MJT.0000000000001497","article-title":"Leflunomide-induced pancytopenia: a case report and literature review.","volume":"30","author":"Aldhafeeri","year":"2023","journal-title":"Am J Ther"},{"key":"R7-20260610","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1179\/102453311X12902908411715","article-title":"Incidence, etiology and bone marrow characteristics of non-chemotherapy-induced agranulocytosis.","volume":"16","author":"Apinantriyo","year":"2011","journal-title":"Hematology"},{"issue":"Suppl 3","key":"R8-20260610","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000499520","article-title":"Extracorporeal blood purification therapies for sepsis.","volume":"47","author":"Monard","year":"2019","journal-title":"Blood Purif"},{"key":"R9-20260610","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/rheumatology\/kep406","article-title":"Severe aplastic anaemia following leflunomide therapy.","volume":"49","author":"W\u00fcsthof","year":"2010","journal-title":"Rheumatology"},{"key":"R10-20260610","doi-asserted-by":"crossref","first-page":"727717","DOI":"10.3389\/fphar.2021.727717","article-title":"Drug-induced idiosyncratic agranulocytosis - infrequent but dangerous.","volume":"12","author":"Rattay","year":"2021","journal-title":"Front Pharmacol"},{"key":"R11-20260610","doi-asserted-by":"crossref","first-page":"139","DOI":"10.14740\/jh837","article-title":"A novel case of leflunomide-induced thrombotic thrombocytopenic purpura.","volume":"10","author":"Shields","year":"2021","journal-title":"J Hematol"},{"key":"R12-20260610","first-page":"1531","article-title":"Usage of oXiris hemofilter for septic shock patients: a single-center experience.","volume":"31","author":"Zhang","year":"2019","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"Suppl 3","key":"R13-20260610","first-page":"1","article-title":"oXiris\u00ae use in septic shock: experience of two French centres.","volume":"47","author":"Schwindenhammer","year":"2019","journal-title":"Blood Purif"},{"key":"R14-20260610","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10067-012-2122-1","article-title":"Leflunomide in dialysis patients with rheumatoid arthritis \u2013 a pharmacokinetic study.","volume":"32","author":"Bergner","year":"2013","journal-title":"Clin Rheumatol"},{"key":"R15-20260610","doi-asserted-by":"crossref","first-page":"e0220444","DOI":"10.1371\/journal.pone.0220444","article-title":"Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: a randomized crossover double-blind study.","volume":"14","author":"Broman","year":"2019","journal-title":"PLoS One"},{"key":"R16-20260610","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3390\/jcm14062113","article-title":"Hemoperfusion using the oxiris membrane in septic shock patients with preserved kidney function: a case series.","volume":"14","author":"Smirnova","year":"2025","journal-title":"J Clin Med"},{"key":"R17-20260610","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13054-023-04555-x","article-title":"Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: a systematic review and meta-analysis.","volume":"27","author":"Wang","year":"2023","journal-title":"Crit Care"},{"key":"R18-20260610","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.3390\/jcm9061808","article-title":"Idiosyncratic drug-induced neutropenia and agranulocytosis in elderly patients.","volume":"9","author":"Lorenzo-Villalba","year":"2020","journal-title":"J Clin Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:02:40Z","timestamp":1781085760000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047138","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2025-04-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}